https://www.selleckchem.com/pr....oducts/rituximab.htm
RYGB had a 36% (HR=0.64, 95% CI 0.55, 0.74) decreased risk of recurrence compared with VSG. A higher number of diabetic medications at the time of surgery and a higher Charlson index score were associated with decreased probability of remission and an increased risk of recurrence of T2DM. While both procedures are initially effective, RYGB may be better than VSG at providing lasting remission of T2DM. While both procedures are initially effective, RYGB may be better than VSG at providing lasting remission of T2DM. Upper-extremity reac
Like
Comment
Share
